CERS2 and Alzheimer disease: Interestingly, the activity of ceramide synthase 2, the enzyme that catalyzes the synthesis of very-long-chain ceramides, decreases in the temporal cortex at early stages and in the frontal cortex at middle-advanced stages, thus showing that alterations of ceramide synthesis occur in the early stages of AD [101].